Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

AMYT
Amryt Pharma plc
stock NASDAQ

Inactive
Apr 11, 2023
14.70USD+0.068%(+0.01)2,389,430
Pre-market
Dec 31, 1969 7:00:00 PM EST
0.00USD-100.000%(-14.69)0
After-hours
Dec 31, 1969 7:00:00 PM EST
0.00USD0.000%(0.00)0
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 28, 2022
07:00AM EST  Amryt Announces Oleogel-S10 EMA Regulatory Update   GlobeNewswire Inc
Jan 18, 2022
07:00AM EST  Amryt Announces New Patents for Oleogel-S10   GlobeNewswire Inc
Jan 11, 2022
07:00AM EST  Amryt Announces Positive Long-TermSafety and Efficacy Data confirming the role for Mycapssa (oral octreotide) in the management of Acromegaly patientswho have responded to and tolerated treatment with octreotide or lanreotide   GlobeNewswire Inc
Jan 6, 2022
02:00AM EST  Key Dates for AIM Delisting   GlobeNewswire Inc
Jan 4, 2022
07:00AM EST  The Lancet Diabetes & Endocrinology Publishes Positive Results for the MPOWERED Phase 3 Trial for Mycapssa (oral octreotide) in Acromegaly Patients   GlobeNewswire Inc
Dec 9, 2021
09:51PM EST  From Benzinga's Global Small Cap Conference: Yield10 Biosciences President & CEO, Oliver Peoples Says Co's Cash Reserves Will Take The Company Through Until 2023   Benzinga
09:50PM EST  From Benzinga's Global Small Cap Conference: Amryt Pharma CFO & COO, Rory Nealon Begins Presenting   Benzinga
09:46PM EST  Benzinga Pro's Top 5 Stocks To Watch For Thursday, Dec. 9, 2021 (Benzinga Global Small Cap Conference Edition): AMYT, YTEN, WRAP, RCRT, MNMD   Benzinga
Nov 23, 2021
09:22AM EST  SVB Leerink Maintains Outperform on Amryt Pharma, Lowers Price Target to $19   Benzinga
08:10AM EST  The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug   Benzinga
07:21AM EST  Amryt Announces FDA PDUFA Goal Date Extended By Three Months To February 28, 2022   Benzinga
07:00AM EST  Amryt Provides Update on Regulatory Review Process for Oleogel-S10   GlobeNewswire Inc
Nov 22, 2021
02:00AM EST  THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 WHICH FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (UK MAR). UPON PUBLICATION OF THIS ANNOUNCEMENT THIS INFORMATION IS NOW CONSIDERED IN THE PUBLIC DOMAIN.   GlobeNewswire Inc
Nov 3, 2021
09:10AM EDT  Earnings Scheduled For November 3, 2021   Benzinga
Oct 4, 2021
11:53AM EDT  JonesTrading Initiates Coverage On Amryt Pharma with Buy Rating, Announces Price Target of $45   Benzinga
Sep 13, 2021
07:31AM EDT  Amryt Raises 2021 Revenue Guidance - Quick Facts   RTTNews
07:14AM EDT  Amryt Lifts FY Revenue Guidance To A Range Of $220 Mln - $225 Mln   RTTNews
Aug 19, 2021
10:10AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2021   Benzinga
09:12AM EDT  SVB Leerink Initiates Coverage On Amryt Pharma with Outperform Rating, Announces Price Target of $22   Benzinga
Aug 18, 2021
05:57AM EDT  The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 5.32 A.M. EDT).   RTTNews
Aug 6, 2021
07:42AM EDT  The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO   Benzinga
Aug 5, 2021
08:08AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO   Benzinga
Jul 27, 2021
11:13AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2021   Benzinga
11:13AM EDT  HC Wainwright & Co. Initiates Coverage On Amryt Pharma with Buy Rating, Announces Price Target of $29   Benzinga
Jun 28, 2021
07:00AM EDT  Publication of Circular to Amryt Shareholders in relation to the acquisition of Chiasma, Inc., and posting of Annual Report and Notices of General Meetings   GlobeNewswire Inc
Jun 15, 2021
06:45AM EDT  Amryt Pharma Announces Filing of Preliminary Registration Statement on Form F-4 in Connection with Its Proposed Acquisition of Chiasma, Inc.   GlobeNewswire Inc
Jun 7, 2021
07:10AM EDT  Amryt: FDA Confirms NDA For Oleogel-S10 Will Not Require An Advisory Committee Meeting   RTTNews
07:00AM EDT  FDA confirms NDA for Oleogel-S10 will not require an Advisory Committee Meeting   GlobeNewswire Inc
Jun 3, 2021
08:23AM EDT  The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout   Benzinga
08:07AM EDT  Amryt Pharma's Oleogel-S10 Application Gets FDA Priority Review Tag for Skin Blistering Disorder   Benzinga
02:00AM EDT  FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa   GlobeNewswire Inc
Jun 2, 2021
08:48AM EDT  Amryt Says FDA Accepted For Filing Its NDA For Oleogel-S10   RTTNews
08:38AM EDT  Amryt Announces FDA Acceptance Of NDA For Oleogel-S10 For Epidermolysis Bullosa   RTTNews
08:38AM EDT  Amryt Announces FDA Acceptance Of New Drug Application For Oleogel-S10 For Treatment Of Epidermolysis Bullosa   Benzinga
May 5, 2021
08:00AM EDT  Chiasma Stock Shoots Up On Being Acquired By Amryt Pharma In All Stock Deal   Benzinga
07:52AM EDT  Chiasma Stock Shoots Up On Amryt's All Stock Acquisition To Strengthen Position In Rare & Orphan Diseases   Benzinga
07:43AM EDT  The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues   Benzinga
07:23AM EDT  UPDATE: Amryt To Exchange 0.396 Amryt ADS Per 1 Chiasma Common Stock   Benzinga
07:23AM EDT  Amryt Reports Will Purchase Chiasma In Stock Deal   Benzinga
07:09AM EDT  Amryt Signs Definitive Agreement To Acquire Chiasma In An All-stock Combination   RTTNews
07:05AM EDT  Amryt Reports Record Q1 2021 Financial and Operating Results   GlobeNewswire Inc
07:00AM EDT  - Combined business will have three approved commercial products,lomitapide (Lojuxta/Juxtapid), metreleptin (Myalept/ Myalepta), octreotide (MYCAPSSA)and a robust clinical pipeline   GlobeNewswire Inc
Mar 31, 2021
10:03AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2021   Benzinga
07:37AM EDT  Maxim Group Initiates Coverage On Amryt Pharma with Buy Rating, Announces Price Target of $27   Benzinga
Mar 29, 2021
02:31AM EDT  Amryt Announces Validation Of MAA For Oleogel-S10 By European Medicines Agency   RTTNews
Mar 26, 2021
04:39PM EDT  Highlights From Day 2 Of Benzinga's Biotech Small Cap Conference   Benzinga
Mar 25, 2021
11:21AM EDT  From BZ Biotech Conference: Amyrt Pharma's Chief Financial Officer, Chief Operating Officer Rory Nealon Concludes Segment   Benzinga
11:18AM EDT  From BZ Biotech Conference: Amyrt Pharma's Chief Financial Officer, Chief Operating Officer Rory Nealon Says Co. Is EBITDA Profitable Along With Revenue Generating Commercial Portfolio; Says Co. Has Enough Cash On Balance Sheet To Achieve Goals   Benzinga
11:16AM EDT  From BZ Biotech Conference: Amyrt Pharma's Chief Financial Officer, Chief Operating Officer Rory Nealon Says Raised $38M Last Year, Highlights $118M Cash On Balance Sheet; Says No Principle Repayment For 4 Years On $125M Convertible Debt   Benzinga
11:13AM EDT  From BZ Biotech Conference: Amyrt Pharma's Chief Financial Officer, Chief Operating Officer Rory Nealon Says Hoping To File With Both FDA, EMA By Year End For Oleogel-S10, Says Key Approval Date Is In December   Benzinga
11:09AM EDT  From BZ Biotech Conference: Amyrt Pharma's Chief Financial Officer, Chief Operating Officer Rory Nealon Highlights Co. Pipeline, Says Global Market Will Double For Lomitapide If Phase 2 Trials Are Successful   Benzinga
11:08AM EDT  From BZ Biotech Conference: Amyrt Pharma's Chief Financial Officer, Chief Operating Officer Rory Nealon Highlights Co. Pipeline, Says Global Market Will Double For Lomitapide Phase 2 Trials Are Successful   Benzinga
Mar 4, 2021
04:07AM EST  Earnings Scheduled For March 4, 2021   Benzinga
Feb 16, 2021
10:38AM EST  Benzinga's Top Ratings Upgrades, Downgrades For February 16, 2021   Benzinga
06:09AM EST  SVB Leerink Initiates Coverage On Amryt Pharma with Outperform Rating, Announces Price Target of $40   Benzinga
Feb 4, 2021
02:00AM EST  Amryt and Medison Pharma Sign Multi-Regional Distribution Agreements in Canada and Israel   GlobeNewswire Inc
Jan 20, 2021
02:00AM EST  Amryt Receives Reimbursement Approval from NICE for Myalepta (metreleptin) in England and Wales   GlobeNewswire Inc
Dec 23, 2020
02:00AM EST  Amryt Granted Orphan Drug Designation by the FDA for AP103   GlobeNewswire Inc
Dec 17, 2020
02:00AM EST  Amryt Receives Ministry of Health Reimbursement Approval for Lojuxta (lomitapide) in Saudi Arabia   GlobeNewswire Inc
Dec 11, 2020
05:00AM EST  TR-1: Standard form for notification of major holdings   GlobeNewswire Inc
Dec 9, 2020
05:36AM EST  Amryt Group Announced Marketing Authorisation Approval for Lojuxta in Brazil   Benzinga
02:00AM EST  Amryt Group Receives Marketing Authorisation Approval for Lojuxta in Brazil   GlobeNewswire Inc
Dec 8, 2020
05:59AM EST  Amryt Announces $40M Private Placement with Leading Biotech Investors; 3.2M ADS's @$12.50/ADS   Benzinga
02:00AM EST  Amryt Announces $40m Private Placement with Leading Biotech Investors   GlobeNewswire Inc
Nov 5, 2020
07:00AM EST  Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue   GlobeNewswire Inc
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Nov 2, 2020
08:59AM EST  Morgan Stanley Maintains Equal-Weight on Rocket Companies, Lowers Price Target to $23   Benzinga
Oct 29, 2020
03:00AM EDT  AMRYT ANNOUNCES POSITIVE RESULTS FROM PHASE 3 TRIAL OF FILSUVEZ IN EPIDERMOLYSIS BULLOSA   GlobeNewswire Inc
Oct 19, 2020
02:00AM EDT  Amryt and Swixx Sign Distribution Deal for Lojuxta   GlobeNewswire Inc
Oct 14, 2020
02:00AM EDT  Notice of Results   GlobeNewswire Inc
Sep 23, 2020
07:00AM EDT  AMRYT SUPPORTS GLOBAL FH AWARENESS DAY   GlobeNewswire Inc
Sep 21, 2020
06:01AM EDT  Exercise of Warrants & Issue of Ordinary Shares and Total Voting   GlobeNewswire Inc
Sep 15, 2020
07:26AM EDT  Amryt: EMA Adopts Positive Opinion For Orphan Designation For Use Of AP103 In Epidermolysis Bullosa   RTTNews
07:00AM EDT  AMRYT RECEIVES POSITIVE OPINION FROM EMA ON ORPHAN DRUG   GlobeNewswire Inc
Sep 9, 2020
12:05PM EDT  Mid-Day Market Update: Dow Jumps Over 500 Points; Trillium Therapeutics Shares Spike Higher   Benzinga
07:01AM EDT  POSITIVE TOP LINE RESULTS FROM PHASE 3 TRIAL IN EB   GlobeNewswire Inc
Aug 11, 2020
06:10AM EDT  AMRYT PHARMA NOTIFICATION OF CANCELLATION OF ADMISSION TO EURONEXT   GlobeNewswire Inc
Aug 6, 2020
07:01AM EDT  AMRYT ANNOUNCES Q2 2020 RESULTS AND ISSUES POSITIVE REVENUE GUIDANCE FOR FY 2020   GlobeNewswire Inc
Jul 29, 2020
07:00AM EDT  AMRYT TO HOST KEY OPINION LEADER CALL ON EPIDERMOLYSIS BULLOSA   GlobeNewswire Inc
Jul 20, 2020
09:32AM EDT  Canaccord Genuity Initiates Coverage On Amryt Pharma with Buy Rating, Announces Price Target of $40   Benzinga
07:00AM EDT  AMRYT TO ANNOUNCE Q2 RESULTS ON AUGUST 6, 2020   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC